HIV Pre-Exposure Prophylaxis Policies Worldwide
An analysis presented at IAS2024, HIV Pre-Exposure Prophylaxis Policies Worldwide, by the Georgetown University Center for Global Health Policy & Politics has found 69% of 194 countries reviewed have approved at least one PrEP product. But only 52% of the countries reviewed follow WHO guidance on PrEP eligibility with regulatory approvals and national policies that support PrEP eligibility for all populations or people at risk.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!